Dual diagnosis - Policy and practice in Italy

American Journal on Addictions

Volumn 15, Issue 2, 2006, Pages 125-130

  Carrà, Giuseppe ^a   Clerici, Massimo ^b  

^a ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

^b UNIVERSITY OF MILAN   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

BUPRENORPHINE; METHADONE; OPIATE;

AGE DISTRIBUTION; COMMUNITY MENTAL HEALTH; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DRUG DEPENDENCE; DRUG DETOXIFICATION; GOVERNMENT; HEALTH CARE FACILITY; HEALTH CARE POLICY; HEALTH EDUCATION; HEALTH PRACTITIONER; HUMAN; MEDICAL EDUCATION; MEDICAL PRACTICE; MEDICAL RESEARCH; MENTAL DISEASE; MENTAL HEALTH; MENTAL HEALTH CARE; METHADONE TREATMENT; PATIENT COUNSELING; PREVALENCE; PRISON; PSYCHIATRIC DIAGNOSIS; PSYCHOSOCIAL CARE; PSYCHOTHERAPY; REVIEW; SUBSTANCE ABUSE;

ADOLESCENT; ADULT; ALCOHOLISM; COMORBIDITY; CROSS-CULTURAL COMPARISON; CURRICULUM; DIAGNOSIS, DUAL (PSYCHIATRY); EDUCATION, MEDICAL, GRADUATE; FEMALE; HEALTH POLICY; HEALTH SERVICES NEEDS AND DEMAND; HUMANS; ITALY; MALE; MENTAL DISORDERS; OPIOID-RELATED DISORDERS; PSYCHIATRY; SPECIALISM; SPECIALIZATION; SUBSTANCE-RELATED DISORDERS;

EID: 33645758801     PISSN: 10550496     EISSN: 15210391     Source Type: Journal    
DOI: 10.1080/10550490500528340     Document Type: Review

References (32)

1. Tansella M, De Salvia D, Williams P. The Italian psychiatric reform: some quantitative evidence. Soc Psychiatry. 1987;22:160-166.
2. de Girolamo G, Cozza M. The Italian psychiatric reform: a 20-year perspective. Int J Law Psychiatry. 2000;23:197-214.
3. Carrà G, Clerici M. The Italian association on addiction psychiatry (SIPDip), formerly the Italian association on abuse and addictive behaviours. Addiction. 2003;98:1039-1042.
4. The WHO World Mental Health Survey Consortium. Prevalence, severity, and unmet need for treatment of mental disorders in the World Health Organization World Mental Health Surveys. JAMA. 2004;291:2581-2590.
5. Clerici M, Carta I, Cazzullo CL. Substance abuse and psychopathology: a diagnostic screening of Italian narcotic addicts. Soc Psychiatry Psychiatr Epidemiol. 1989;24:219-226.
6. Pani PP, Trogu E, Contu P, Agus A, Gessa GL. Psychiatric severity and treatment response in a comprehensive methadone maintenance treatment program. Drug Alcohol Depend. 1997;48:119-126.
7. Fioritti A, Ferri S, Galassi L, Warner R. Substance use among the mentally ill: a comparison of Italian and American samples. Community Ment Health J. 1997;33:429-442.
8. Clerici M, Carta I. Personality disorders among psychoactive substance users: diagnostic and psychodynamic issues. Eur Addict Res. 1996;2:147-155.
9. Pozzi G, Bacigalupi M, Tempesta E. Comorbidity of drug dependence and other mental disorders: a two-phase study of prevalence at outpatient treatment centres in Italy. Drug Alcohol Depend. 1997;46:69-77.
10. Welfare Department. Relazione Annuale al Parlamento sullo stato delle Tossicodipendenze in Italia, 2003. Italian Welfare Department. Available at: http://www.governo.it/GovernoInforma/Dossier/droga_relazione/Relazione2003.pdf. Accessed October 28, 2004.
11. Clerici M, Carrà G. Thirty-six-month follow up of opiate dependents in three levels of treatment intensity. In: Carrà G, Clerici M, eds. Dual Diagnosis: Filling the Gap. Esher: John Libbey Eurotext Surrey, UK; 2003:85-91.
12. Hibell B, Andersson B, Ahlström S, et al. The 1999 ESPAD Report. The European School Survey Project on Alcohol and Other Drug Use among Students in Thirty European Countries. Stockholm: The Swedish Council for Information on Alcohol and Other Drugs; 2000.
13. Department of Justice. Statistiche Sull'esecuzione negli Istituti Penitenziari 2003. Dipartimento dell'Amministrazione Penitenziaria. Available at: http://www.giustizia.it/statistiche/statistiche_dap/2003/dicembre/ det200312_toss.htm. Accessed October 28, 2004.
14. Carrà G, Giacobone C, Pozzi F, Alecci P, Barale F. Prevalence of mental disorder and related treatments in a local jail: a twenty-month consecutive case study. Epidemiol Psichiatr Soc. 2004;13:47-54.
15. European Monitoring Centre for Drugs and Drug Addiction. Annual Report 2003: The State of the Drugs Problem in the European Union and Norway. EMCDDA. Available at: http://annualreport.emcdda.eu.int/download/ar2003eu_en.pdf. Accessed October 28, 2004.
16. Department of Health. Rilevazione 2001 del Personale e Strutture dei Dipartimenti di Salute Mentale. Roma: Direzione Generale della Prevenzione Ufficio XI; 2002.
17. Drake RE, Mercer-McFadden C, Mueser KT, McHugo GJ, Bond GR. Review of integrated mental health and substance abuse treatments for patients with dual disorders. Schizophr Bull. 1998;24:589-608.
18. Nizzoli U, Foschini V. ERIT-Italia, the Italian federation for professionals working in the field of drug abuse. Addiction. 2002;97:1365-1367.
19. Carrà G, Scioli R, Barale F. Un Servizio di Consultazione per la Comorbidità Psichiatrica nei Disturbi da Uso di Sostanze. Presidenza del Consiglio dei Ministri-Dipartimento per gli Affari Sociali. Terza conferenza nazionale sui problemi connessi con la diffusione delle sostanze stupefacenti e psicotrope. Genova 28-30 Novembre 2000. Available at: http://www.genovaduemila. it/documenti/relazioni/n_00_carra.pdf. Accessed October 28, 2004 (in Italian).
20. European Board of Psychiatry. Charter on Training of Medical Specialists in The EU: Requirements for the Speciality of Psychiatry, 2003. European Union of Medical Specialists. Available at: http://www.uemspsychiatry.org/board/ reports/Chapter6-11.10.03.pdf. Accessed October 28, 2004.
21. World Psychiatric Association. World Psychiatric Association Institutional Program on the Core Training Curriculum for Psychiatry. Yokohama: World Psychiatric Association; 2002.
22. OECD Observer. OECD in Figures. Statistics on the Member Countries. 2004 ed. Paris: OECD; 2004.
23. Maremmani I, Zolesi O, Aglietti M, et al. Methadone dose and retention during treatment of heroin addicts with Axis I psychiatric comorbidity. J Addict Dis. 2000;19:29-41.
24. Pani PP, Trogu E, Carboni GF, Palla P, Loi A. Psychiatric severity and treatment response in methadone maintenance treatment programmes: new evidence. Heroin Addiction & Related Clinical Problems. 2003;5:22-36.
25. Gerra G, Ferri M, Polidori E, Santoro G, Zaimovic A, Sternieri E. Long-term methadone maintenance effectiveness: psychosocial and pharmacological variables. J Subst Abuse Treat. 2003;25:1-8.
26. Gerra G, Borella F, Zaimovic A, et al. Buprenorphine versus methadone for opioid dependence: predictor variables for treatment outcome. Drug Alcohol Depend. 2004;75:37-45.
27. Solomon J, Fioritti A. Motivational intervention as applied to systems change: the case of dual diagnosis. Subst Use Misuse. 2002;37:1833-1851.
28. Pozzi G, Del Borgo C, Del Forno A, Genualdo A, Mannelli P, Fantoni M. Psychological discomfort and mental illness in patients with AIDS: implications for home care. AIDS Patient Care STDS. 1999;13:555-564.
29. Tondo L, Baldessarini RJ, Hennen J, et al. Suicide attempts in major affective disorder patients with comorbid substance use disorders. J Clin Psychiatry. 1999;60(Suppl 2):S63-S69.
30. Ferri M, Davoli M, Perucci CA. Heroin maintenance for chronic heroin dependents. Cochrane Database Syst Rev. 2003; Issue 3. Art. No.: CD003410. DOI: 10.1002/14651858.CD003410.
31. Miller SI, Frances R. Psychiatrists and the treatment of addictions: perceptions and practices. Am J Drug Alcohol Abuse. 1986;12: 187-197.
32. Crome IB. Dissemination of current treatment research findings to the profession, policy makers and patients - whose responsibility is it? Addiction. 2000;12:1767-1769.